---
title: IVD_China Insights Report 2024
description: IVD_China Insights Report 2024
---

[Skip to content](https://events.clearstate.com/ivd_china-insights-report-2024#main-content)

![Clearstate](https://events.clearstate.com/hs-fs/hubfs/Asset%203@3x-8.png?width=3492&height=574&name=Asset%203@3x-8.png)Homepage

# IVD China Insight Report 2024

 China’s IVD market is at a turning point. What was once one of the fastest-growing diagnostics markets globally is now facing contraction, shaped by volume-based procurement (VBP), DRG reforms, and the assertive rise of domestic manufacturers. Our latest Clearstate China IVD Market Insight Report 2024 takes a closer look at how these forces are redefining the competitive landscape — and where the opportunities still lie.

[Download](https://events.clearstate.com/ivd_china-insights-report-2024#register)

![Clearstate\_China\_IVD](https://events.clearstate.com/hubfs/Clearstate_China_IVD.jpg)

## Key Takeaways

### Fragmented scale

130,000+ labs nationwide, but fewer than 5,000 NABL-accredited

### Urban–rural imbalance

Urban–rural imbalance: 65% of the population lives outside cities, yet advanced diagnostics remain concentrated in metros.

### Consolidation effect

 4–5 national lab networks already control ~35% of urban diagnostic volumes.

### Growth hotspots

Molecular diagnostics (+11% CAGR) and tissue diagnostics (+14% CAGR) are set to outpace the market.

### Hub-and-spoke expansion

Organized lab networks are driving digital adoption, home collection, and access to smaller towns.

## China IVD Insights Report 2024 – Now Available

 Download the latest insights into China’s IVD market and discover key trends shaping the future.

© 2026 Clearstate. All rights reserved.

[Privacy Policy](https://events.clearstate.com/privacy-policy?hsLang=en)